• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 05 Aug 2019

JPMorgan Indian Investment Trust - Overview


JPMorgan Indian Investment Trust PLC (JII:LON) | 1,071 107.1 0.9% | Mkt Cap: 702.5m


  • Kepler | Trust Intelligence
    • William Heathcoat Amory

    • 6 pages


 

JPMorgan Indian (JII) owns a portfolio of Indian equities, with a bias to quality and managers who prefer to take a long-term investment horizon. The trust aims to maximise capital growth by selecting companies with the potential to grow their earnings faster than the market over the long run. The managers, Rukhshad Shroff and Rajendra Nair, are willing to pay a premium for the best growth opportunities, so the trust tends to trade on a higher valuation than the index. The approach is active, having an active share of 61% and zero weightings in some of the largest stocks in the benchmark, as well as zero weightings to sectors that the managers believe are less appealing. Over the long run this approach has paid off, with the trust outperforming the MSCI India index over five years in NAV total return terms. However, the managers’ active approach worked against them in 2017 and 2018, as two companies they do not own have led the market upwards. Ruhkshad and Rajendra have been in charge of the portfolio since 2003, giving them extensive experience in this market. They can draw on the research of a broad team covering the emerging markets region, specialised by sector and working to a clearly defined research process aimed at identifying the best growth opportunities. As the above suggests, running the portfolio as actively as they do means that short-term returns may deviate from the market by a wide margin. The portfolio is relatively highly concentrated, with 62% held in the top ten positions, the highest proportion of the four closed-ended India funds. The portfolio also has the highest beta out of the three closed-ended finds that have a five-year track record, and the only beta above 1. The managers have used gearing sparingly in the past, given the higher beta nature of the portfolio and the volatility that comes with investing in a single country. The trust aims for capital growth and does not pay a dividend. The trust has traded on a persistent discount in recent years. Over five years, the average has been 12%, although in 2019 it has tightened somewhat to 9.7%. The board will hold a tender offer for up to 25% of the company’s shares at NAV less costs should the portfolio underperform the benchmark in the three years to September 2019. At the time of writing, the trust’s NAV has underperformed the MSCI India index by 12.9% since October 2016.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

JPMorgan Indian Investment Trust - Overview


JPMorgan Indian Investment Trust PLC (JII:LON) | 1,071 107.1 0.9% | Mkt Cap: 702.5m


  • Published: 05 Aug 2019
  • Author: William Heathcoat Amory
  • Pages: 6
  • Kepler | Trust Intelligence


JPMorgan Indian (JII) owns a portfolio of Indian equities, with a bias to quality and managers who prefer to take a long-term investment horizon. The trust aims to maximise capital growth by selecting companies with the potential to grow their earnings faster than the market over the long run. The managers, Rukhshad Shroff and Rajendra Nair, are willing to pay a premium for the best growth opportunities, so the trust tends to trade on a higher valuation than the index. The approach is active, having an active share of 61% and zero weightings in some of the largest stocks in the benchmark, as well as zero weightings to sectors that the managers believe are less appealing. Over the long run this approach has paid off, with the trust outperforming the MSCI India index over five years in NAV total return terms. However, the managers’ active approach worked against them in 2017 and 2018, as two companies they do not own have led the market upwards. Ruhkshad and Rajendra have been in charge of the portfolio since 2003, giving them extensive experience in this market. They can draw on the research of a broad team covering the emerging markets region, specialised by sector and working to a clearly defined research process aimed at identifying the best growth opportunities. As the above suggests, running the portfolio as actively as they do means that short-term returns may deviate from the market by a wide margin. The portfolio is relatively highly concentrated, with 62% held in the top ten positions, the highest proportion of the four closed-ended India funds. The portfolio also has the highest beta out of the three closed-ended finds that have a five-year track record, and the only beta above 1. The managers have used gearing sparingly in the past, given the higher beta nature of the portfolio and the volatility that comes with investing in a single country. The trust aims for capital growth and does not pay a dividend. The trust has traded on a persistent discount in recent years. Over five years, the average has been 12%, although in 2019 it has tightened somewhat to 9.7%. The board will hold a tender offer for up to 25% of the company’s shares at NAV less costs should the portfolio underperform the benchmark in the three years to September 2019. At the time of writing, the trust’s NAV has underperformed the MSCI India index by 12.9% since October 2016.

More Content

More Content

JPMorgan Indian

Companies: JPMorgan Indian Investment Trust PLC

Kepler | Trust Intelligence

Analyst Interview - JPMorgan Indian Investment Trust

Companies: JPMorgan Indian Investment Trust PLC

Edison

JPMorgan Indian

Companies: JPMorgan Indian Investment Trust PLC

Kepler | Trust Intelligence

JPMorgan Indian - Overview

Companies: JPMorgan Indian Investment Trust PLC

Kepler | Trust Intelligence

JPMorgan Indian

Companies: JPMorgan Indian Investment Trust PLC

Kepler | Trust Intelligence
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In